These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 8094437)
1. Stability of GR63178A, a novel pentacyclic pyrroloquinone anticancer compound, in aqueous solutions and biological fluids. French RC; Cummings J; Nicolson M; Smyth JF J Pharm Pharmacol; 1993 Jan; 45(1):10-5. PubMed ID: 8094437 [TBL] [Abstract][Full Text] [Related]
2. Chromatographic characterisation of six human metabolites of the new anticancer drug GR63178A. Cummings J; French RC; MacLellan A; Smyth JF Cancer Chemother Pharmacol; 1991; 28(1):27-32. PubMed ID: 2040030 [TBL] [Abstract][Full Text] [Related]
3. A phase I and pharmacology study of GR63178A, a water-soluble analogue of mitoquidone. Eccles DM; Cummings J; Stewart ME; Nicolson M; Cornbleet MA; Leonard RC; Smyth JF Cancer Chemother Pharmacol; 1992; 29(5):375-8. PubMed ID: 1551176 [TBL] [Abstract][Full Text] [Related]
4. High-performance liquid chromatographic separation and quantitation of benzisoquinolinedione (Nafidimide) from biological fluids. Lu K; Savaraj N; Newman RA J Chromatogr; 1985 Dec; 345(2):408-12. PubMed ID: 4086609 [No Abstract] [Full Text] [Related]
5. Studies on the molecular pharmacology of GR63178A. A novel pentacyclic pyrolloquinone anticancer drug. Cummings J; Graham MA; Hoey BM; Butler J; Fry AM; Hickson ID; Leonard G; French R; Smyth JF Biochem Pharmacol; 1992 Aug; 44(3):433-9. PubMed ID: 1324674 [TBL] [Abstract][Full Text] [Related]
6. The comparative disposition of the pyrolloquinone GR63178A and its 9-hydroxy metabolite GR54374X in sensitive and resistant mouse colon adenocarcinoma. French RC; Cummings J; MacLellan A; MacPherson JS; Ritchie AA; Smyth JF Cancer Chemother Pharmacol; 1993; 32(2):156-61. PubMed ID: 8485810 [TBL] [Abstract][Full Text] [Related]
7. High-performance liquid chromatographic assay for the experimental anticancer agent oxantrazole. Frank SK; Mathiesen DA; Whitfield LR; Ames MM J Chromatogr; 1987 Aug; 419():225-32. PubMed ID: 3667780 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of the stability of linezolid in aqueous solution and commonly used intravenous fluids. Taylor R; Sunderland B; Luna G; Czarniak P Drug Des Devel Ther; 2017; 11():2087-2097. PubMed ID: 28744100 [TBL] [Abstract][Full Text] [Related]
9. Photodegradation of irinotecan (CPT-11) in aqueous solutions: identification of fluorescent products and influence of solution composition. Dodds HM; Craik DJ; Rivory LP J Pharm Sci; 1997 Dec; 86(12):1410-6. PubMed ID: 9423156 [TBL] [Abstract][Full Text] [Related]
10. Chemical stability of ecomustine, a new antitumor agent in aqueous and biological media as assessed by high-performance liquid chromatography. el Abed I; Roger P; Gosse C; Atassi G; Gouyette A Cancer Chemother Pharmacol; 1991; 27(4):295-300. PubMed ID: 1998985 [TBL] [Abstract][Full Text] [Related]
11. Sensitive reversed-phase high-performance liquid chromatographic assay for the antitumor agent benzisoquinolinedione (Nafidimide) employing direct on-column injection of plasma and urine, and its use for pharmacokinetic studies in a dog. Powis G; Kroschel DM; Moore DJ J Chromatogr; 1985 Dec; 345(2):402-7. PubMed ID: 4086608 [No Abstract] [Full Text] [Related]
12. Aqueous solubility and degradation kinetics of the phytochemical anticancer thymoquinone; probing the effects of solvents, pH and light. Salmani JM; Asghar S; Lv H; Zhou J Molecules; 2014 May; 19(5):5925-39. PubMed ID: 24815311 [TBL] [Abstract][Full Text] [Related]
14. The aqueous stability of bupropion. O'Byrne PM; Williams R; Walsh JJ; Gilmer JF J Pharm Biomed Anal; 2010 Nov; 53(3):376-81. PubMed ID: 20547024 [TBL] [Abstract][Full Text] [Related]
15. Stability and degradation profiles of Spantide II in aqueous solutions. Kikwai L; Babu RJ; Kanikkannan N; Singh M Eur J Pharm Sci; 2006 Feb; 27(2-3):158-66. PubMed ID: 16266798 [TBL] [Abstract][Full Text] [Related]
16. Degradation study of the investigational anticancer drug clanfenur. Sluiter C; Kettenes-van den Bosch JJ; Hop E; van der Houwen OA; Underberg WJ; Bult A Int J Pharm; 1999 Aug; 185(2):227-35. PubMed ID: 10460918 [TBL] [Abstract][Full Text] [Related]
17. Degradation of a novel tripeptide, tert-butoxycarbonyl-Tyr-Leu-Val-CH2Cl, with inhibitory effect on human leukocyte elastase in aqueous solution and in biological fluids. Tokumitsu H; Fukumori Y; Tsuda Y; Okada Y; Kasuya F; Igarashi K; Fukui M Chem Pharm Bull (Tokyo); 1997 Nov; 45(11):1845-50. PubMed ID: 9396162 [TBL] [Abstract][Full Text] [Related]
18. Study of forced degradation behavior of enalapril maleate by LC and LC-MS and development of a validated stability-indicating assay method. Bhardwaj SP; Singh S J Pharm Biomed Anal; 2008 Jan; 46(1):113-20. PubMed ID: 17964751 [TBL] [Abstract][Full Text] [Related]
19. Study of the stability of tylosin A in aqueous solutions. Paesen J; Cypers W; Pauwels K; Roets E; Hoogmartens J J Pharm Biomed Anal; 1995 Aug; 13(9):1153-9. PubMed ID: 8573642 [TBL] [Abstract][Full Text] [Related]
20. High-performance liquid chromatographic assay for the separation and characterization of metabolites of the potential cytostatic drug oracine. Wsól V; Kvasnicková E; Szotáková B; Hais IM J Chromatogr B Biomed Appl; 1996 May; 681(1):169-75. PubMed ID: 8798926 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]